Načítá se...
Bone Marrow Derived Mesenchymal Stromal Cells from Sickle Cell Disease Patients Display Intact Functionality
Hematopoietic cell transplantation (HCT) is the only cure for sickle cell disease (SCD), but engraftment remains challenging in patients lacking matched donors. Infusion of mesenchymal stromal cells (MSCs) at time of HCT may promote hematopoiesis and ameliorate graft-versus-host disease. Experimenta...
Uloženo v:
| Vydáno v: | Biol Blood Marrow Transplant |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5390328/ https://ncbi.nlm.nih.gov/pubmed/28132869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.01.081 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|